Free Generics: A New Marketing Gimmick
Lipitor’s generic equivalent is now being offered at no cost by some US retailers! Apparently generics have gone from providing a less expensive solution to high drug costs, to serving as a shopping incentive. Large retail stores like Wegmans, a national food market chain, are reportedly offering a number of common generics to their customers free of charge as a new marketing gimmick.
Overcoming Drug Shortages in Canada
According to recent surveys, 30% of Canadians have to deal with major drug shortages – especially for chemo-therapeutics, antibiotics, anti-epileptics and anesthetics. These shortages are becoming increasingly common throughout the country. As a result, there has been a notable decline in the health and medical condition of Canadian patients, an increase in negative reactions to substitute drugs, cancellation of procedures, and increased costs both to patients and the health care system.
LC Provides Interpreting Services for J&J Russia
Janssen Pharmaceutica, a subsidiary of Johnson & Johnson, has selected Language Connections on various occasions to provide interpreting services for their important business meetings. We are pleased that they continue to choose us to ensure communication for high level business meetings and presentations when quality and accuracy are critical. We use only top notch Russian interpreters that are highly proficient in the material which is being discussed. Later this month we will be providing a consecutive Russian interpreter for an international business meeting.
About Language Connections:
Language Connections is one of the top language service companies in the US. Over the last 30 years, we’ve focused on providing the best business translation services, interpreting services, as well as interpreter training and customized language training programs. In addition to top-tier corporate language training, we offer certified corporate interpreters and professional business translation services in 200+ languages. Our network includes linguists with backgrounds in all major industries. They’re ready to meet your needs, whether they’re for technical translation services, legal translation, government translation services, international development translation services, education translation services, life sciences translation, or something else. Reach out to us today for a free quote on our cost-efficient and timely translation services, interpreters, or other linguistic services.
Language Connections LLC
2001 Beacon Street, Suite 105,
Boston, MA 02135
Phone: +1-617-731-3510
Email: service@languageconnections.com
USRussia Chamber of Commerce of NE Event
Russian Investment & Massachusetts Technology –
A Winning Combination
Russian investment funds have become a new source of financing for Massachusetts technology companies. Practical collaboration includes not only investment, but access to Russian markets and research resources. On March 13. a special program was hosted by the US – Russia Chamber of Commerce of New England which brought together companies that are interested in collaborating with Russian investment companies. The event featured a panel discussion which was presented by representatives from five Massachusettes companies currently receiving Russian funding from companies such as Rusnano and Maxwell Biotech. The panel focused on the opportunities and practical aspects of funding through Russian investment funds. Our company President, and Director of the US-Russia Chamber of Commerce, Leo Galperin attended the meeting.
Keynote speakers:
Dmitry Akhanov, President & CEO, Rusnano USA
Alexey Eliseev, Managing Director, Maxwell Biotech * Panel Discussion:
Selecta Biosciences, Werner Cautreels, CEO
BIND Biosciences, Scott Minick, CEO
Joule Unlimited, William Sims, President & CEO
Dental Photonics, Alexander Vybornov, President & CEO
Bionevia Pharmaceuticals, Tim Barberich, CEO
About Language Connections:
Language Connections is one of the top language service companies in the US. Over the last 30 years, we’ve focused on providing the best business translation services, interpreting services, as well as interpreter training and customized language training programs. In addition to top-tier corporate language training, we offer certified corporate interpreters and professional business translation services in 200+ languages. Our network includes linguists with backgrounds in all major industries. They’re ready to meet your needs, whether they’re for technical translation services, legal translation, government translation services, international development translation services, education translation services, life sciences translation, or something else. Reach out to us today for a free quote on our cost-efficient and timely translation services, interpreters, or other linguistic services.
Language Connections LLC
2001 Beacon Street, Suite 105,
Boston, MA 02135
Phone: +1-617-731-3510
Email: service@languageconnections.com
Best Practices 2012 Drug Trademarks
According to experts, between 1980 and 2010 the number of pharmaceutical trademarks filed increased over 300%. Although 238,010 pharmaceutical trademarks were filed globally in 2010, there were only 21 new drugs approved by the US Food and Drug Administration (FDA) and 14 new molecular entities approved by the European Medicines Agency (EMA). In 2011, the US FDA’s approval of new drugs was the highest it had been in seven years, with a total of 30 new drugs. The trend is consistent in subsequent years, with an average of 30 new drugs approved a year. The number of approvals reached its peak in 2015, when the US FDA approved 45 new drugs.
Pharmaceutical companies can face some problems when filing a new trademark or commercial name for their drugs. In order to avoid expanding the already lengthy process of getting your drug approved, the FDA gives companies the following tips:
- Avoid obvious similarities in both sound or spelling with other drugs already registered
- Do not use medical abbreviations or the name of inactive ingredients that are present in the drug
- Either use all of the names of the active ingredients for the trademark, or don’t use any at all; it could lead the patient to think that only some of them are actually present on the drug
- Don’t reuse the proprietary name of a drug that contains different active ingredients
In order to avoid these problems and seeking to be prepared in the event that the first name they had in mind doesn’t fulfill the FDA’s requirements, pharmaceutical companies have come up with various systems. In combination with the filing of a greater number of trademark applications, some companies have instituted standard commercialization guidelines and procedures to initiate trademark development as early as the end of Phase I. Others have earmarked an annual budget for the creation and maintenance of a ‘name bank’ to prepare for a potential candidate shortfall or regulatory rejection. One benefit that has resulted from this is the ability to match fast-moving licensing opportunities with a set of names that have cleared the preliminary screening process.
A number of key lessons can be learned from this that can be applied by all companies interested in naming a new molecular entity. These are some recommended best practices for drug trademark:
- Employ a team of professionals to develop a formalized process
- Employ experts who have experience with FDA and EMA trademark requirements
- Begin the process early so that this does not become the limiting factor
- Identify the proper balance of creativity and clearance to help ensure a successful outcome
Are trademarks names suitable for international markets?
Pharmaceutical companies sell worldwide, not just locally. However, when the time comes to enter the international market, many of them may face the fact that some trademarks don’t work as good out of the country they were created in. In these cases, the need for partnering with a professional language service provider (LSP) seems obvious.
Some international markets are specially hard to penetrate, as they have hard, specific regulations regarding languages. One good example for this would be the European Union (EU), with 28 member states, most of them requiring the documents that accompany the drug to be translated to their official language(s).
Even though using machine translation or a bilingual internal staff member could look like a fast, money saving solution when getting into the translation phase, it would be a smart move to search for professional localization and translation services. A professional LSP will grant you not only proficiency in the source and target languages, but also expertise in the two different cultures and the pharmaceutical industry. Moreover, it will ensure that the whole translation process undergoes a thorough quality assurance procedure, so that it meets the highest quality standards.
If done wrong, life sciences translation can cost more than money, and the producer will always be liable for any problems that may arise. Trusting your trademark and accompanying documents translation to a LSP will save you the trouble.
About Language Connections:
Language Connections is one of the top language service companies in the US. Over the last 30 years, we’ve focused on providing the best business translation services, interpreting services, as well as interpreter training and customized language training programs. In addition to top-tier corporate language training, we offer certified corporate interpreters and professional business translation services in 200+ languages. Our network includes linguists with backgrounds in all major industries. They’re ready to meet your needs, whether they’re for technical translation services, legal translation, government translation services, international development translation services, education translation services, life sciences translation, or something else. Reach out to us today for a free quote on our cost-efficient and timely translation services, interpreters, or other linguistic services.
Language Connections LLC
2001 Beacon Street, Suite 105,
Boston, MA 02135
Phone: +1-617-731-3510
Email: service@languageconnections.com
The Pharmaceutical Market in Argentina
The Pharmaceutical Market in Argentina
Argentina is one of the fast growing pharmaceutical markets in Latin America. It has an approximate revenue share of 10% of the total Latin American pharmaceutical market, and the third largest market in Latin America.
Following Argentina’s 2001 economic crisis, many international companies left the country, while local companies used the opportunity to enter the biomanufacturing industry. This remains the case to a large extent today, with 71% of Argentinean pharmaceutical production taking place in national laboratories. In fact, out of all companies operating in the pharmaceutical sector, over half are domestic. Despite the dominance of domestic companies – and as a result of Argentina’s highly promising market – there has been an increased collaboration between domestic and foreign companies.
Look for our contribution in the April 2012 GBI Research Pharma Executive Summary Report
(for free member access go to www.globalbusinessintelligence.com).
The report discusses various factors which have influenced the pharmaceutical market in Argentina, such as: the outlook for generics vs non-generic drugs in the country today, recent changes in healthcare coverage or legislature, and which domestic companies are successfully collaborating with foreign investors.
About Language Connections:
Language Connections is one of the top language service companies in the US. Over the last 30 years, we’ve focused on providing the best business translation services, interpreting services, as well as interpreter training and customized language training programs. In addition to top-tier corporate language training, we offer certified corporate interpreters and professional business translation services in 200+ languages. Our network includes linguists with backgrounds in all major industries. They’re ready to meet your needs, whether they’re for technical translation services, legal translation, government translation services, international development translation services, education translation services, life sciences translation, or something else. Reach out to us today for a free quote on our cost-efficient and timely translation services, interpreters, or other linguistic services.
Language Connections LLC
2001 Beacon Street, Suite 105,
Boston, MA 02135
Phone: +1-617-731-3510
Email: service@languageconnections.com
EDC Adoption and Life Science Translation in Global Trials
With the expansion of pharmaceuticals’ clinical research into emerging countries, many companies are pushing for better life sciences translation services and global electronic data capture (EDC) adoption in an effort to improve the efficiency and accuracy of patient data collection methods. Although there are many advantages to converting to a paperless system, there are several new challenges that have arisen in the process. Limited IT, limited life sciences translation services, inadequate training in EDC technology and language barriers have all contributed to the relatively slow progress of EDC adoption in international clinical trials.
Look for Our Article about Life Sciences Translation and Global Clinical Trials
Our life sciences expert has recently published an article in the February 2012 issue of International Clinical Trials entitled “Communication Crossroads“ which discusses these issues. The article brings to light the limitations due to inadequate technology and infrastructure in many emerging countries, as well as the importance of a unified translation system to ensure data accuracy.
About Language Connections:
Language Connections is one of the top language service companies in the US. Over the last 30 years, we’ve focused on providing the best business translation services, interpreting services, as well as interpreter training and customized language training programs. In addition to top-tier corporate language training, we offer certified corporate interpreters and professional business translation services in 200+ languages. Our network includes linguists with backgrounds in all major industries. They’re ready to meet your needs, whether they’re for technical translation services, legal translation, government translation services, international development translation services, education translation services, life sciences translation, or something else. Reach out to us today for a free quote on our cost-efficient and timely translation services, interpreters, or other linguistic services.
Language Connections LLC
2001 Beacon Street, Suite 105,
Boston, MA 02135
Phone: +1-617-731-3510
Email: service@languageconnections.com
Life Sciences Translation Services for Global Operations via Partnerships
Forming international partnerships is becoming an increasingly common trend among companies that want to fully optimize their access to global markets (as is using life sciences translation services to make everything run smoothly). More and more life science companies are looking for partners that can bring together technological expertise, information assets and resources to help them optimize their operations and enhance their entrance into global markets. Multinational pharmaceuticals often enter emerging markets by acquiring domestic generics and manufacturing companies in order to facilitate cost savings, accounting for 50% of all mergers and acquisitions between 2008 and 2010. Read on to learn more.
Pharmaceutical Translation and Brazil’s Market

According to the National Ministry of Health, Brazil will be in need for some pharmaceutical translation services! Their market has grown by $28 billion annually, backed strongly by generics sales. Although government programs largely support generics, Brazil’s president has also encouraged long-term foreign investment in the country’s pharmaceutical industry. Keep reading to see how and why companies that know how to work in Brazil are finding their place in this fast growing market.
FDA Will Need Interpretation Services to Address Globalization Issues
The drug development, production, and distribution landscape in the United States has changed dramatically in recent years, expanding the FDA’s responsibilities across new borders (and requiring lost of interpreting services). According to recent statistics, up to 40 % of the drugs in the United States are imported, and up to 80% of the active pharmaceutical ingredients in those drugs are produced abroad. This globalization, along with increased outsourcing, has posed new challenges that requires the FDA to refocus its drug review process.

